ICYMI, this week we had stories about melanoma management with pembrolizumab, advances in rosacea therapy, new phase 2 data of VP-315 for BCC, and more.
Although our tax code changes somewhat regularly, both real estate and cash value life insurance have shown superior tax treatment for decades.
Click here to answer this week's poll.
This week's edition of the Mainstream Patient features stories about addictive behaviors stemming from skin care culture, the 21 best hyaluronic acid serums, and the struggles behind finding the right vitiligo treatment.
When compared to a vehicle control cream, researchers said delgocitinib cream proved more efficacious.
Researchers said the treatment may improve post-acne erythema.
The risk remained significantly increased for both sexes as well ,whether or not the patient had depression, substance use disorder, or alcohol use disorder.
At least 1 legal case suggests that providers have a duty to minimize risks during the transition period to a new electronic health record system.
With dermoscopy and skin thickness assessments, researchers said it may be possible to detect cutaneous-involved acromelagy.
Such factors may include transepidermal water loss and skin barrier function.
Learning from mentors and developing a solid foundation in dermatology are just a few of the necessary steps to boost your career as a dermatology APP.
ASLAN Pharmaceuticals will present 2 late-breaking abstracts and 2 additional abstracts.
Learn more about the in-depth topics covered in the April 2023 issue of Dermatology Times®.
In this week’s Pointers with Portela, the 208SkinDoc explains why vitamin C serums can occasionally have an unpleasant smell.
Patients more commonly reported skin aging manifestations when they experienced higher levels of stress.
Galderma announced the approval of a injectable poly-L-lactic acid to correct fine lines and wrinkles.
Physical activity and exercise may lead to improved mental health but exacerbate skin conditions.
The results of a new study reveal that the antibody works by activating the immune response to fight cancer and slows melanoma growth in mice.
Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are popular for the month of April.
Inhibitor etanercept alleviated pathological changes and inflammation in induced psoriasis.
Results of a new study indicate that baricitinib offers a potential therapeutic option with a favorable benefit-risk profile for pediatric patients with moderate-to-severe AD.
Using mass spectrometry, researchers examined novel changes to gather updated metastasis information.